These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36566915)
1. Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway. Fang S; Zheng L; Shen L; Su Y; Ding J; Chen W; Chen X; Chen W; Shu G; Chen M; Zhao Z; Tu J; Ji J Eur J Pharmacol; 2023 Feb; 940():175465. PubMed ID: 36566915 [TBL] [Abstract][Full Text] [Related]
2. RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo. Li G; Liu L; Shan C; Cheng Q; Budhraja A; Zhou T; Cui H; Gao N Cell Death Dis; 2014 Jan; 5(1):e998. PubMed ID: 24434521 [TBL] [Abstract][Full Text] [Related]
3. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin. Zheng Y; Ouyang Q; Fu R; Liu L; Zhang H; Hu X; Liu Y; Chen Y; Gao N Cell Death Dis; 2018 May; 9(6):656. PubMed ID: 29844397 [TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Lee S; Choi EJ; Jin C; Kim DH Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433 [TBL] [Abstract][Full Text] [Related]
5. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway. Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922 [TBL] [Abstract][Full Text] [Related]
6. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. Fu X; Tian J; Zhang L; Chen Y; Hao Q FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665 [TBL] [Abstract][Full Text] [Related]
7. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation. Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431 [TBL] [Abstract][Full Text] [Related]
8. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer. Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308 [TBL] [Abstract][Full Text] [Related]
9. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms. Wu H; Cao Y; Weng D; Xing H; Song X; Zhou J; Xu G; Lu Y; Wang S; Ma D Cancer Lett; 2008 Nov; 271(2):260-71. PubMed ID: 18657898 [TBL] [Abstract][Full Text] [Related]
10. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Yan X; Fraser M; Qiu Q; Tsang BK Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the met receptor tyrosine kinase signaling enhances the chemosensitivity of glioma cell lines to CDDP through activation of p38 MAPK pathway. Lou X; Zhou Q; Yin Y; Zhou C; Shen Y Mol Cancer Ther; 2009 May; 8(5):1126-36. PubMed ID: 19435873 [TBL] [Abstract][Full Text] [Related]
12. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway. Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627 [TBL] [Abstract][Full Text] [Related]
13. Mir-22-3p Enhances the Chemosensitivity of Gastrointestinal Stromal Tumor Cell Lines to Cisplatin through PTEN/PI3K/Akt Pathway. Xu Y; Cheng M; Mi L; Qiu Y; Hao W; Li L Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):318-325. PubMed ID: 30537795 [TBL] [Abstract][Full Text] [Related]
14. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway. Kong C; Zhu Z; Li Y; Xue P; Chen L Clin Transl Oncol; 2021 Jul; 23(7):1334-1341. PubMed ID: 33515421 [TBL] [Abstract][Full Text] [Related]
16. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway. Chen Q; Qin R; Fang Y; Li H Cell Physiol Biochem; 2015; 36(3):956-65. PubMed ID: 26087719 [TBL] [Abstract][Full Text] [Related]
17. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer. Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103 [TBL] [Abstract][Full Text] [Related]
18. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer. Li N; Men W; Zheng Y; Wang H; Meng X Molecules; 2019 Nov; 24(23):. PubMed ID: 31801250 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway. Cao Y; Xia F; Wang P; Gao M Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway. Li Y; Ye Y; Feng B; Qi Y J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]